|
 |
FDA Approval Activities for this Drug…
Betaxon (levobetaxolol hydrochloride ophthalmic suspension),0.5%, Alcon Universal,Limited NDA 21-114 2/29/00 Betaxon Indication: for lowering intraocular pressure in patients with chronic open-angle glaucoma or ocular hypertension. Dosage form/route of administration is new
For the most up-to-date approval information, please locate this API using the drug index. For industry specific content, please visit USActives.com. |
|
|